Ultragenyx Pharmaceutical Inc.

DB:UP0 Stock Report

Market Cap: €4.2b

Ultragenyx Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:UP0 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
10 Oct 24Sell€360,494Howard HornIndividual7,465€48.29
03 Sep 24Sell€4,632Theodore HuizengaIndividual91€50.90
03 Sep 24Sell€1,011,779Emil KakkisIndividual20,000€50.59
06 Aug 24Sell€917,810Emil KakkisIndividual20,000€45.89
02 Jul 24Sell€22,291Corazon SandersIndividual584€38.17
12 Jun 24Sell€406,807Karah ParschauerIndividual9,806€41.49
10 Jun 24Sell€66,450Corazon SandersIndividual1,737€38.26
02 May 24Sell€14,446Eric CrombezIndividual354€40.81
18 Apr 24Sell€5,873Eric CrombezIndividual142€41.36
11 Mar 24Sell€525,857Thomas KassbergIndividual11,509€45.69
07 Mar 24Sell€567,705Matthew FustIndividual12,195€46.56
01 Mar 24Sell€236,770Erik HarrisIndividual4,768€49.66
01 Mar 24Sell€16,933Theodore HuizengaIndividual341€49.66
01 Mar 24Sell€207,223John PinionIndividual4,173€49.66
01 Mar 24Sell€61,477Eric CrombezIndividual1,238€49.66
01 Mar 24Sell€50,204Thomas KassbergIndividual1,011€49.66
01 Mar 24Sell€186,516Karah ParschauerIndividual3,756€49.66

Insider Trading Volume

Insider Buying: UP0 insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of UP0?
Owner TypeNumber of SharesOwnership Percentage
State or Government39,3810.0427%
General Public360,9330.391%
Individual Insiders3,223,7013.49%
Institutions88,651,33096.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.4%.


Top Shareholders

Top 25 shareholders own 66.37% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.8%
The Vanguard Group, Inc.
9,945,473€447.3m1.69%0.01%
6.32%
BlackRock, Inc.
5,828,848€262.2m4.02%no data
5.55%
Sands Capital Management, LLC
5,118,255€230.2m-4.42%0.59%
4.51%
Wellington Management Group LLP
4,165,424€187.3m-8.58%0.03%
3.33%
T. Rowe Price Group, Inc.
3,068,654€138.0m2.56%0.01%
2.91%
Emil Kakkis
2,684,984€120.8m22.6%no data
2.89%
State Street Global Advisors, Inc.
2,664,077€119.8m-1.22%no data
2.73%
Alkeon Capital Management, LLC
2,517,434€113.2m34.8%0.86%
2.63%
ClearBridge Investments, LLC
2,426,977€109.2m3.11%0.08%
2.29%
Federated Hermes, Inc.
2,110,700€94.9m0.17%0.23%
2.14%
Rock Springs Capital Management LP
1,978,272€89.0m2.82%3.07%
2.13%
RTW Investments, LP
1,968,002€88.5m-39.6%1.25%
1.83%
Deutsche Asset & Wealth Management
1,688,971€76.0m-5.24%0.02%
1.79%
Invesco Ltd.
1,647,617€74.1m33%0.02%
1.71%
Baker Bros. Advisors LP
1,576,114€70.9m7.47%0.68%
1.7%
Geode Capital Management, LLC
1,571,081€70.7m4.36%0.01%
1.68%
AllianceBernstein L.P.
1,546,265€69.5m1.2%0.02%
1.65%
Adage Capital Management, L.P.
1,525,741€68.6m35.6%0.12%
1.27%
Alyeska Investment Group, L.P.
1,170,007€52.6m1,570%0.26%
1.25%
Suvretta Capital Management, LLC
1,151,314€51.8m-44.2%1.95%
1.12%
AQR Capital Management, LLC
1,034,234€46.5m968%0.06%
1.09%
Norges Bank Investment Management
1,002,463€45.1m0%no data
1.08%
Emerald Advisers, LLC
999,100€44.9m13.9%0.96%
1.07%
Two Sigma Advisers, LP
987,800€44.4m123%0.1%
0.93%
Point72 Asset Management, L.P.
861,687€38.8m58.9%0.1%